Crackdown on Capitol riot ‘terrorism’ means arrests of people in Congress and around Trump: former FBI asst. director
RT | June 9, 2021
A former FBI deputy director has declared hundreds of Americans terrorists, and called for the arrest of sitting members of Congress, all over the notion that the pro-Trump riot on Capitol Hill was “terrorism.”
Hundreds of participants in the pro-Trump riot on Capitol Hill in January have been arrested and charged, with many held in deplorable prison conditions ahead of trial. With current FBI Director Christopher Wray testifying to Congress that the riot was an act of “domestic terrorism,” former Assistant Director Frank Figliuzzi appeared on MSNBC on Tuesday to call for even tougher action against the MAGA rioters.
“Arresting low-level operatives is merely a speed bump, not a road block,” he claimed. “In order to really tackle terrorism – and this time domestically – you’ve got to attack and dismantle the command and control element of a terrorist group.”
“Unfortunately,” he continued, “that may mean people sitting in Congress right now. People in and around the former president.”
The language used by Figliuzzi is more commonly used by officials to describe foreign terror groups, rather than mobs of unruly Americans. However, such words have been liberally deployed by intelligence officials, Democratic lawmakers, and journalists in the wake of the Capitol riot. Despite the hyperbole, many rioters were simply allowed inside the Capitol to loiter and snap selfies, and of the five deaths connected to the riot, only one (the shooting dead of an unarmed Trump supporter by a police officer) has been proven to be directly inflicted by another person.
While many of the aforementioned officials, lawmakers, and reporters have clamored for expanded surveillance powers and domestic terror laws in the wake of the riot, Figliuzzi’s comments come the closest yet to outright accusing Republican leaders of orchestrating “terrorism.”
Figliuzzi’s comments drew outrage from conservatives and opponents of the intelligence community. “We should demand that every senior FBI official, from Wray to the lowest level supervisory agent denounce this talk and make clear this lunacy is unacceptable,” security analyst Kyle Shideler tweeted. “If they do not, shutter the agency forever.”
That the FBI, or at least the agency’s former officials, would associate support for Trump with terrorism is unsurprising. FBI brass broke agency rules to spy on Donald Trump’s campaign and knew no evidence existed linking the Trump team to Russia, but investigated the supposed links anyway.
Figliuzzi was fully on board with the ‘Russiagate’ hoax, telling MSNBC’s Brian Williams after a meeting between Trump and Russian President Vladimir Putin in July 2018 that Trump was “compromised financially or personally” by Russia and therefore had “made the decision to side with the other team.” Figliuzzi gave no evidence for his claims.
Even now, long after Special Counsel Robert Mueller’s investigation found no evidence that Trump “colluded” with Russia in the runup to the 2016 election, Figliuzzi still insists that this collusion took place, and parrots the debunked story that Russia allegedly paid Taliban fighters in Afghanistan “bounties” to kill American troops.
Why a Judge Has Georgia Vote Fraud on His Mind: ‘Pristine’ Biden Ballots That Looked Xeroxed
By Paul Sperry | RealClearInvestigations | June 8, 2021
When Fulton County, Ga., poll manager Suzi Voyles sorted through a large stack of mail-in ballots last November, she noticed an alarmingly odd pattern of uniformity in the markings for Joseph R. Biden. One after another, the absentee votes contained perfectly filled-in ovals for Biden — except that each of the darkened bubbles featured an identical white void inside them in the shape of a tiny crescent, indicating they’d been marked with toner ink instead of a pen or pencil.

Brian Amero: The judge, a donor to Democrats, ordered ballots unsealed for inspection after poll workers swore under oath Biden votes looked fake. https://www.co.henry.ga.us/
WHO’s Chief Scientist Served with Legal Notice for Disinformation and Suppression of Evidence
By Colin Todhunter | OffGuardian | June 9, 2021
On 25 May 2021, the Indian Bar Association (IBA) served a 51-page legal notice on Dr Soumya Swaminathan, the Chief Scientist at the World Health Organisation (WHO), for:
[H]er act of spreading disinformation and misguiding the people of India, in order to fulfil her agenda.”
The Mumbai-based IBA is an association of lawyers who strive to bring transparency and accountability to the Indian justice system. It is actively involved in the dissemination of legal knowledge and provides guidance and support to advocates and ordinary people in their fight for justice.
The legal notice says Dr Swaminathan has been:
Running a disinformation campaign against Ivermectin by deliberate suppression of effectiveness of drug Ivermectin as prophylaxis and for treatment of COVID-19, despite the existence of large amounts of clinical data compiled and presented by esteemed, highly qualified, experienced medical doctors and scientists,”
And:
Issuing statements in social media and mainstream media, thereby influencing the public against the use of Ivermectin and attacking the credibility of acclaimed bodies/institutes like ICMR and AIIMS, Delhi, which have included ‘Ivermectin’ in the ‘National Guidelines for COVID-19 management’.”
The IBA states that legal action is being taken against Dr Swaminathan in order to stop her from causing further damage to the lives of citizens of India.

Dr Soumya Swaminathan, WHO Chief Scientist
The notice is based on the research and clinical trials carried out by the ‘Front Line COVID-19 Critical Care Alliance’ (FLCCC) and the British Ivermectin Recommendation Development (BIRD) Panel. These organisations have presented an enormous amount of data that strengthen the case for recommending Ivermectin for the prevention and treatment of COVID-19.
The IBA says that Dr Swaminathan has ignored these studies and reports and has deliberately suppressed the data regarding the effectiveness of Ivermectin, with an intent to dissuade the people of India from using it.
However, two key medical bodies, the Indian Council for Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) Delhi, have refused to accept her stand and have retained the recommendation for Ivermectin, under a ‘May Do’ category, for patients with mild symptoms and those in home isolation, as stated in ‘The National Guidelines for COVID-19 management’.
It is interesting to note that the content of several web links to news articles and reports included in the notice served upon Dr Swaminathan, which was visible before issuing the notice, has either been removed or deleted.
It seems that the vaccine manufacturers and many governments are desperate to protect their pro-vaccine agenda and will attempt to censor information and news regarding the efficacy of Ivermectin.
The legal notice can be read in full on the website of the India Bar Association.
Is there a Problem with the Lopez-Medina, Colombia-based Study Implicating Ivermectin?
Major Pharma Companies Including Merck Funding the Trial Site during the Study
By Michael B. Goodkin MD, FACC | TrialSite News | June 9, 2021
Although a great majority of ivermectin-based studies have indicated real promise, one particular study conducted by a small trial site in Colombia received unprecedented media attention when the study results indicated negligible impact. What hasn’t been disclosed by media is the seriously questionable pharmaceutical industry support of this one trial site. During the study, a handful of some of the largest drug companies in the world gave this site money. What’s not clear is why this occurred and whether the funds are correlated to some nefarious agenda. This author suggests that the publisher should have scrutinized this industry funding perhaps more carefully.
On March 4th, 2021, an article appeared in JAMA titled, “Effect of Ivermectin On Time To Resolution of Symptoms Among Adults With Mild COVID.” It concluded, “The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes.”
Dr. Eduardo Lopez-Medina et al. from Cali, Colombia, randomized 400 mildly ill patients, averaging 37 years old, to ivermectin 0.3 mg/kg or placebo. The time to resolution for ivermectin-treated patients was 10 days and placebo patients 12 days, which was not statistically significant.
Much has been written about the methodologic problems of the study but few read to the bottom of the article to see this:
Conflict of Interest Disclosures: Dr. López-Medina reported receiving grants from Sanofi Pasteur, GlaxoSmithKline, and Janssen as well as personal fees from Sanofi Pasteur during the conduct of the study. Dr. Oñate reported receiving grants from Janssen and personal fees from Merck Sharp & Dohme and Gilead outside the submitted work. Dr. Torres reported receiving nonfinancial support from Tecnoquímicas unrelated to this project during the conduct of the study. No other disclosures were reported.
Considerable press outlets noted this study, we suspect due to the fact that the ivermectin results were negligible, but none of the media addressed the possibility of conflict with industry.
Absolutely nothing has been written about the fact that the study was sponsored by Centro de Estudios en Infectogía Pediatrica and the authors were paid by 3 drug companies making COVID vaccines–Sanofi Pasteur, GlaxoSmithKline, and Janssen– and two making COVID therapeutics–Gilead and Merck.
We have some questions about this. Why did the authors disclose that they were receiving industry sponsor funds during the conduct of the study? Were these funds to actually direct the ivermectin study? That would most certainly be a conflict of interest material.
Merck’s expressed their intent on competing against the ivermectin generic approach. Why would this company be funding this small trial site operation in Colombia?
How could JAMA even think about publishing an article sponsored by 5 drug companies centering on a study targeting a generic competitor? Any layperson seeing this could think that this was highly suspect.
The potential conflict of interest was so severe that no journal should have published it.
Why would anyone do this study?
Was there a pressing need to know if 37-year-old patients got better sooner with ivermectin than placebo? There were a lot of resources put into this study. The only possible reason to do the study was for drug companies to have a vehicle to publish negative data about ivermectin. Is there anyone who believes the study was sponsored to add to the scientific knowledge about ivermectin for the treatment of COVID?
On February 4th, 2021, Merck, who had the original patent on ivermectin, put out a statement regarding ivermectin for COVID:
• No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;
• No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease; and
• A concerning lack of safety data in the majority of studies.
If Merck believed these statements to be true, why would they feel the need to go public with them?
Merck’s vaccine had failed. Merck had bought a company, Oncoimmune, for $425 million and gotten $356 million from HHS in taxpayer money to develop a therapeutic agent, CD24c. They had a material conflict of interest. Later, the European Medicines Agency and World Health Organization both quoted Merck’s statement while ignoring the conflict of interest and science in recommending against the use of ivermectin for COVID, other than for research. Were they influenced by Merck? CD24c was dropped, and Merck has oral antiviral molnupiravir in a phase II-III trial. Why would Merck sponsor a trial of ivermectin?
Why would JAMA publish an article showing that young patients who are expected to recover quickly don’t get better much more quickly with ivermectin?
This article did not warrant publication in JAMA. The only possible reason to publish it was to present false, negative information about ivermectin to readers.
Why was the age of the patients not mentioned in the key findings or conclusions?
The age of the patients made the article irrelevant. It could not have been an accident that the age was not mentioned in the key findings and conclusions. That would never happen at JAMA. The authors anticipated that many readers would miss the age of the patients and conclude that ivermectin is ineffective in early COVID. Dr. Adfarsh Bhimraj at Cleveland Clinic who heads the committee writing COVID recommendations for the Infectious Disease Association of America spoke with Helio Medical News on ivermectin. He had a similar observation in the Washington Post.
“This was a well-done, but small trial in patients with mild or moderate disease,” Bhimraj said. He suggested that this is a negative study for a non-mortality outcome, but because the numbers were small, it might not have produced a statistically significant difference in effect size. The evidence is not enough to warrant a recommendation for the use of ivermectin. Other US experts who commented on the article have failed to notice the age of the patients and drug company sponsorship. It has crossed few American physicians’ minds that JAMA could be corrupted and knowingly publish a study with deceptive results in order to help drug companies.
Was the data fraudulent?
If the purpose of the article was to make it appear that ivermectin was ineffective in mild COVID, there is no reason to believe the data was real. There is no published randomized data for comparison. In the Dominican Republic, Dr. Jose Natalio Redondo reported that in 1300 patients with all degrees of illness, the length of illness went from 21 days to 10 days with ivermectin treatment.
Was JAMA aware that there was concern they had been corrupted and the article unreliable?
Sixteen members of the AMA Board of Directors were emailed that it appeared that JAMA had been infiltrated and the article fraudulent on March 10th, 2021. Eleven JAMA editorial board members were emailed about it April 12th. And one was spoken to. The same email was sent to executive editor Dr. Phil Fontanarosa April 13th. This reply was sent:
“Your message was brought to my attention.
I will look into these issues as outlined in your letter.
Please bear with me, as this will take some time, given the number of issues and the complexity of the concerns you raise, as well as other urgent issues and priorities we are addressing right now.”
As of 6/8/21, the article has been read online 759,000 times. How many of those readers concluded that ivermectin is ineffective for mild COVID and, as a result, did not prescribe it for their patients? To put things in perspective, Uttar Pradesh, India, with 210 million people, started ivermectin in August. By December, their mortality rate was 0.26 per 100,000. In the US, in December, it was 11 times higher at 2.8 per 100,000. Admissions in Mexico are down 75% due to ivermectin.
The JAMA article of 3/4/21 was a cleverly devised drug company creation designed to create the false impression that ivermectin was ineffective in mild COVID by claiming it didn’t shorten the duration of illness significantly. They knew people would miss the age of the patients and not read to the bottom of the article to see that it was sponsored by 5 drug company competitors. They knew people would leap to the conclusion that ivermectin was completely ineffective for COVID, not realizing that the article could not address its effects on hospitalization and death. An infectious disease doctor friend sent it to me as proof that ivermectin does not work. Drug companies would not have gone to these lengths if they did not fear ivermectin as a competitor.
JAMA reviewers could not possibly have missed the obvious conflict of interest. It was obviously their intention to spread misinformation. Leaving out the age of the patients was intentional to make readers think it was ineffective in everyone. The article has not only led to patient care being adversely affected but the article has been widely quoted as evidence against the use of ivermectin. WHO says it is the number one article in support of its position.
Doctors should contact JAMA to understand what is going on with the investigation. JAMA should report on their findings as they committed to this author to undertake an investigation.
Pharma Controlled FDA Approves Inadequately Tested Alzheimer’s Drug
By Stephen Lendman | June 9, 2021
According to the Alzheimer’s Association, around 6 million Americans suffer from the degenerative disease.
The number is projected to more than double by 2050.
One in three US seniors dies from Alzheimer’s disease or dementia — more than breast and prostate cancer combined.
In 2021, treating Alzheimer’s and dementia patients cost an estimated $355 billion.
By 2050, the cost is expected to be about $1.1 trillion.
Over 11 million American families have one or more members afflicted by these diseases.
From 2000 – 2019, US deaths from heart disease declined by 7.3% while individuals in the country dying from Alzheimer’s disease rose by 145%.
Professor of Medicine, medical ethics and neurology Dr. Jason Karlawish is board certified to practice geriatric medicine.
Among his extensive credentials, he heads the University of Pennsylvania’s Neurodegenerative Disease Ethics and Policy Program, is associate director of the Clinical Core and co-associate director of the Alzheimer’s Disease Core Center, as well as co-director of the Penn Memory Center.
He’s involved with the Healthy Brain Research Network.
It’s dedicated to surveillance, education, awareness, empowerment and promotion of brain health.
He heads makingsenseofalzheimers.org at the University of Pennsylvania’s Neurodegenerative Disease Ethics and Policy Program.
As part of his research on neuroethics and policy, he investigated issues in dementia drug development, informed consent, quality of life, and treatment decision-making.
On May 30 — days before the FDA’s premature approval of Biogen’s experimental, inadequately tested aducanumab Alzheimer’s drug — Karlawish minced no words saying the following:
If approved, “I won’t prescribe it,” adding:
When asked if any new safe and effective drugs exist to treat Alzheimer’s disease, he unequivocally said, “No.”
He’s been saying the same thing “for the past 18 years,” he explained.
Drugs he prescribes to ease cognitive problems “are only moderately effective.”
No magic bullet otherwise exists.
No drugs slow cognitive impairment to let affected individuals maintain control over their lives.
He and colleagues involved in treating Alzheimer’s patients won’t prescribe aducanumab because “Biogen hasn’t made a convincing case for it,” he explained, adding:
“The consequences of FDA approval are as disturbing as they are vast.”
Millions of “Americans could be prescribed aducanumab, at an estimated cost that ranges from $20,000 to $50,000 per person per year.”
“Biogen claims the benefits of slowing declines in cognition and day-to-day function are worth this price.”
Karlawish disagrees, saying Biogen data are “murky.”
“(T)he drug’s benefits are ambiguous at best and not worth this cost.”
“Putting it on the market will stress Medicare’s resources.”
Dubious benefits will force families of Alzheimer’s patients to decide if the high cost is worth the risks posed by the drug.
One risk “is small bleeds in the brain, a risk that is heightened in those with the APOE4 gene, a gene associated with late-onset Alzheimer’s disease,” Karlawish explained.
“Aducanumab is not the drug to launch a new era of Alzheimer’s treatment.”
“It hasn’t been properly studied…so the FDA has incomplete data to form a judgment.”
What’s going on is “good for business but bad for science and patient care.”
According to investors.com, after aducanumab failed two final-phase studies in March 2019, Biogen’s stock lost a third of its value.
After a phase-three test suggested promise — despite 10 members of an FDA advisory committee recommending against its approval — Biogen’s stock rose over 30%.
According to biotech company Cassava Sciences’ CEO Remi Barbier, the anti-amyloid approach used by Biogen “failed repeatedly…for the past 25 – 30 years, adding:
“Normally, when an approach fails, sometimes you try again.”
“Certainly, three strikes and you’re out.”
“It’s been 20 strikes and they’re still batting.”
Biogen is a troubled company.
According to investors.com, generics are eating into sales of its biggest moneymaker, the multiple sclerosis treatment Tecfidera.”
“In the first quarter, Tecfidera sales plunged 56%.”
In partnership with Ionis Pharmaceuticals, sales of Biogen’s spinal muscular atrophy drug Spinraza fell about 8%.
Is FDA approval of aducanumab more about preventing Biogen’s bankruptcy than treating Alzheimer’s patients safely and effectively?
Before the drug’s approval, macreoaxis rated possible Biogen bankruptcy at 28.56% because of its troubled financial situation.
In Phase 2 clinical trials, the FDA let Biogen “skip a crucial step in drug development…to assure that the final phase of testing (Phase 3) will make a convincing case that the drug should be marketed to providers and patients,” Karlawish explained, adding:
“Biogen’s application for approval divided the FDA.”
Its advisory committee sided with the yeas over the neas even though the latter case was much more convincing.
Company data on aducanumab are “incomplete and contradictory,” said Karlawis.
“Skipping a key phase of research” was a business, not a science-based, decision.
Families with an Alzheimer’s disease member are grasping at whatever may offer hope.
The verdict on aducanumab won’t be known unless “Biogen invests the time and money needed to run well-designed trials and complete them,” Karlawis stressed.
Given premature FDA approval, they’re highly unlikely to be conducted.
Aducanumab users will be playing Russian roulette with their health by volunteering as virtual guinea pigs with an inadequately developed drug that may make a bad situation worse.
Questions as Israel intelligence officer dies in detention
MEMO | June 8, 2021
Mystery has shrouded the death of an Israeli military intelligence officer in prison three weeks ago after he was accused of committing crimes that harmed the state, local media reported on Monday.
The Israeli military said that “the investigation uncovered suspicions that the officer, who served in a technology unit in the Intelligence Directorate, knowingly took actions that severely harmed state security.”
Haaretz reported the military saying: “The officer cooperated during his investigation and confessed to many of the deeds that were attributed to him.”
Information about the case was revealed after the military scaled back a complete gag order on it, but, according to the Times of Israel, key details about the affair, including the officer’s identity and the exact nature of his alleged crimes, remain barred from publication.
The Israeli military said, according to the Times of Israel, that the soldier acted alone and did not commit the actions on behalf of a foreign government, for financial reasons or as a result of a specific ideology, but rather for unspecified “personal motivations”.
Meanwhile, Haaretz reported the soldier’s relatives saying: “We are confused, we are frightened and we want real answers.”
“No one has explained to us what happened.”
The soldier was arrested in August. He was found injured in his prison cell on 17 May and died later in hospital.
Critiquing Nature and the Lancet over their disinformation, but making huge material omissions while doing so. Who is Ian Birrell?
By Meryl Nass, M.D. | June 8, 2021
Below are excerpts from a very interesting Unherd article by Ian Birrell, who previously wrote about the lab leak hypothesis when it was very difficult to get anything published on it. Birrell’s reportage is good, as far as it goes. But he lets Fauci, Farra and Collins off the hook. He ponders whether Chinese money influenced the “debt-ridden” Nature publishing company. It surely could have.
But one should also be asking, why is the (formerly?) world’s top science magazine, Nature, the most important journal in the world in which to publish science, debt-ridden in the first place?
And Birrell deftly avoided the more obvious conclusion that if Farrar, Fauci and Collins initiated the Nature Medicine paper to produce faulty scientific arguments against a lab leak, wouldn’t they have been the ones to place it in Nature Medicine, not China?
Birrell did something else strange. He notes that Farrar directed him to the Nature Medicine paper as the scientific basis for the natural origin claim. But he fails to mention that the Fauci emails now show that Farrar was involved in crafting that paper, and involved his employee Josie Golding, who also signed the Daszac-written March 7 Lancet Correspondence, in its crafting. Though not a coauthor, she was quoted in the press release the Scripps Institute issued about the paper. From the Fauci emails, we now know that Kristian Andersen, the first author, emailed Fauci, Farrar and Collins to thank them for their “advice and leadership” on the paper.
Thus this otherwise interesting article is a limited hangout. While criticizing Nature Medicine and the Lancet, and attempting to grab the high road, Ian Birrell reveals himself to be a purveyor of slanted news.
There are two other interesting things about Ian Birrell. He produced one of the earliest mainstrem articles on the lab hypothesis with Alina Chan, back in February. In hindsight, were they being set up then as trusted sources if the lab hypothesis gained prominence?
But who is Ian Birrell? His earlier claim to fame was as a speechwriter for David Cameron. Everyone knows what that means. He was a professional crafter of lying narratives. This Unherd article is designed to blame China and misdirect away from the role of the US and UK’s top science funders: Fauci, Jeremy Farrar and Francis Collins.
https://unherd.com/2021/06/beijings-useful-idiots/
Nature Medicine, its sister publication, was also home for the second key commentary that set the tone in the scientific community after Daszak’s outing in The Lancet. “The proximal origin of Sars-CoV-2″ bluntly concluded that “we do not believe that any type of laboratory-based scenario is plausible”. Critics pointed out it was questionable to claim there was any “evidence” proving that Sars-CoV-2 is not a purposefully manipulated virus. Others noted that the statement mentions the mysterious furin cleavage site — which Nikolai Petrovksy drew attention to as allowing the spike protein to bind effectively to cells in human tissues yet which is not found in the most closely-related coronaviruses — but downplays its potential significance. The statement suggests “it is likely that Sars-CoV-2-like viruses with partial or full polybasic cleavage sites will be discovered in other species”. This has not happened so far.
This document — whose five signatories include one expert who was handed China’s top award for foreign scientists after nearly 20 years work there, and another who is a “guest professor” for the Chinese Centre for Disease Control and Prevention — has been accessed 5.4 million times and cited almost 1,500 times in other papers. It is so influential that when I emailed Jeremy Farrar, director of the Wellcome Trust and one of The Lancet signatories, to see if his stance remained the same, he pointed me to this paper that he called “the most important research on the genomic epidemiology of the origins of this virus”.
The lead author was Kristian Andersen, an immunologist at Scripps Research Institute in California who has been a very active voice on social media condemning the lab leak theory and confronting its proponents. Yet the recent release of emails to Anthony Fauci exposed that Andersen had previously admitted to the National Institute of Allergy and Infectious Diseases director that the virus had unusual features that “(potentially) look engineered” and which are “inconsistent with expectations from evolutionary theory”. He claimed last week the discussion was “clear example of the scientific process” but as another top scientist said to me: “What a smoking gun!”. Now Anderson’s twitter account has suddenly disappeared…
[According to Rutgers professor Richard Ebright,] “Nature and The Lancet played important roles in enabling, encouraging, and enforcing the false narrative that science evidence indicates Sars-CoV-2 had a natural-spillover origin points and the false narrative that this was the scientific consensus”.
Or as another well-placed observer put it: “The game seems to be for Nature and The Lancet to rush non-peer revised correspondences to set the tone and then delay critical papers and responses.”
But why would they do this? This is where things become even murkier. Allegations swirl that it was not down to editorial misjudgement, but something more sinister: a desire to appease China for commercial reasons…
Lawyer Sue Grey to NZ government: Failure to cease Covid vaccination programme may constitute homicide
NZ Outdoors Party | June 5, 2021
URGENT REQUEST FOLLOWING RESEARCH SHOWING “S PROTEIN” IS A TOXIN
To: Rt Hon Jacinda Ardern <jacinda.ardern@parliament.govt.nz>, Hon David Parker <david.parker@parliament.govt.nz>, Hon Andrew Little <andrew.little@parliament.govt.nz>, Hon Chris Hipkins <chris.hipkins@parliament.govt.nz>, <ashley_bloomfield@moh.govt.nz>, Chris James <Chris.James@health.govt.nz>, <ayesha.verrall@parliament.govt.nz>
Dear Prime Minister, Attorney-General, Minister of Health, Minister of Covid, Minister or Seniors, Director General of Health and Chris Hipkins
I attach below some new and very important research which I must assume your advisors have not yet provided to you, or the experimental Pfizer injection rollout would surely already have been suspended.
It is now clearly established that the S-Protein [spike protein] is a toxin that causes the harmful symptoms known as “Covid”.
I surely don’t need to explain the legal, ethical and human rights consequences of a government knowingly promoting a program which intentionally injects a life threatening toxin into healthy people.
I also attach a report indicating that injected nanoparticles (and the S-Protein) do not remain in the arm muscle but instead circulate throughout the whole body.
The combined effect is that the Pfizer jab injects mRNA to take over cells to manufacture the deadly S-Protein toxin and this spread throughout much of the body, manufacturing the S-Protein toxin for days and in some cases many weeks.
This explains why even the limited available research from the two months of study as summarised in the Comirnaty Data Sheet identifies possible harm to many different parts of the body including the heart, blood, brain, musculoskeletal system, nervous system, fainting and dizziness etc.
This is no longer just a shocking experiment. Everyone involved is now on notice of this “injection roulette” which may result in death or serious injury to previously healthy people. The health and safety implications for employers and those who push this jab, are significant.
No post injection death can legitimately be ruled out as being caused or contributed by the injection, at least not without a full coroner’s report. Certainly any post vax stroke, heart attack, other blood disorder, nervous system disorder or even suicide or car accident (known overseas as “vaccidents”) must prima facie be assumed to be caused or contributed to by the jab, at least until a full coroners report is undertaken.
Similarly it is not good enough to claim that our seniors who die post jab were frail and likely to die. Surely if they were that frail they should have been spared from the jab. Anyway, surely “deaths post Jab” should be treated consistently with “deaths post Covid”.
Despite the secretive, flawed and very passive official post jab injury reporting process ( CARM), and as a result of the more active community led follow up, you are already on notice of a number of deaths and life threatening and life changing harm from this injection. The deaths and harm will inevitably continue if there are any further injections. Perhaps initially you had an excuse that you thought the S-Protein was “safe”. However now you are on notice that it is not “safe” by any definition.
Further, although you in privileged position are on notice, many members of the public who you were elected to represent remain deceived by misleading claims in crown propaganda that the jab is “safe and effective”. In these circumstances there can be no “Informed consent”. Each jab without Informed Consent is in breach of the Health and Disability Code and is an assault.
In these circumstances, the ongoing program is surely criminal, and indeed may result in Homicide as defined by the Crimes Act:
158 Homicide defined
Homicide is the killing of a human being by another, directly or indirectly, by any means whatsoever.
Compare: 1908 No 32 s 173
Anyone who aids, abets or otherwise incites homicide is a party to that homicide.
I note that the Director-General of Health has shared his view in sworn evidence that Covid is the most serious health issue for New Zealand in 100 years.
I invite you all to consider that claim very carefully and critically. Please put Covid in perspective against the many other challenges which we face, including for example heart attacks, strokes, cancer, suicide accidents and diabetes and the nitrate and other contamination of much of our water.
Surely you must agree that the harm is not from “Covid” but from the “Response to Covid”.
The best expert evidence is that the risk from Covid is similar to the risk from influenza. Many experts are now saying that Covid is simply a rebranding of influenza and colds, supported by PCR testing that was never intended as a diagnostic tool. The WHO says that PCR testing should not be used beyond 20-25 cycles. OIA responses indicate that in NZ PCR tests use up to 45 cycles, which simply multiplies any contamination.
Our government is about to enter dangerous new phase if it proceeds to inject more healthy New Zealanders with an injection that experts have established is toxic.
Apart from the direct harm to those who choose, or are bullied to accept this injection, there is considerable peripheral harm. This includes the contamination of our Blood Bank with S-Protein. We can only speculate on the risks for vulnerable people who receive blood contaminated with this toxin.
Please stop and reflect. Please listen to international experts who are independent from Big Pharma and who are not invested in the Covid paradigm.
Please listen to the New Zealand scientific and medical experts who have put their careers and reputations on the line out of extreme concern.
Please correct the misinformation that this injection is “safe and effective” and “approved by Medsafe” when in fact it did not meet the statutory criteria that “benefit exceeds risk”.
There is no imminent health risk from suspending the program. Dr Bloomfield’s sworn evidence was that the risks were mainly financial and reputational.
Please find the courage to challenge whoever is driving this, and any who act on dogma rather than evidence, reason or ethics.
The future of New Zealand depends on your courage to step up and make this critical call for our people.
I urge you to listen, engage and act in the public interest.
Please put aside your pride and the dogma, and suspend this program.
I am happy to assist however I can.
Sue Grey LLB (Hons), BSc (Biochemistry and Microbiology), RSHDipPHI
Co-leader NZ Outdoors Party (https://www.outdoorsparty.co.nz)
academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab465/6279075
We Should Welcome the Lab Leak Theory, Argues Biologist
By Noah Carl • Lockdown Sceptics • June 8, 2021
At the start of the pandemic, many of us were puzzled as to why the lab leak hypothesis was considered “racist” but the wet market hypothesis was not. Both theories said the pandemic began in China, and both implied that some Chinese people had acted carelessly. (In reality, of course, neither theory is “racist”.)
The most likely reason why the lab leak theory came to be seen as “racist” is that this was convenient for several key organisations, who wanted to avoid any suggestion that they might have helped to cause the pandemic. These organisations include the Chinese Communist Party, the Wuhan Institute of Virology, the National Institutes of Health, and EcoHealth Alliance.
The fact that President Trump endorsed the lab leak theory also played a role, of course. Left-wing media outlets in the US have a habit of assuming that, if Trump says something, then it must – almost by definition – be racist.
In a recent article for UnHerd, the biologist Bret Weinstein argues that we should actually welcome the lab leak theory. This is because, if it turns out to be true, we know how to prevent future pandemics of this kind. Simple: ban the research until we can figure out how to do it safely. (Or at the very least: ramp up lab security.)
However, if the zoonotic spillover theory is correct, then “it’s only a matter of time before something like this happens again. And again. And again.” As Weinstein notes, “The straightforward lesson of the pandemic would be to simply face up to the clear risk of studying dangerous, novel infectious agents in the lab.”
He goes on to argue that, if the virus did escape from a lab, then one of the pandemic’s ultimate causes is the distorted incentives that led scientists to undertake such dangerous research in the first place. According to Weinstein:
… the scientific method has been hijacked by a competition over who can tell the most beguiling stories. Scientists have become salesmen, pitching serious problems that they and their research just so happen to be perfectly positioned to solve. The fittest in this game are not the most accurate, but the most stirring. And what could be more stirring than a story in which bat caves are ticking pandemic time-bombs from which only the boldest and brightest gene experts can save us?
Weinstein’s article contains a lot of interesting details, and is worth reading in full.
The Coming Biden/Putin Train-Wreck Summit
By Ron Paul | June 7, 2021
I have my doubts whether the Putin-Biden summit in Geneva will take place later this month, but even if somehow it is pulled off, recent Biden Administration blunders mean the chance anything of substance will be achieved is virtually nil.
The Biden Administration was supposed to signal a return of the “adults” to the room. No more bully Trump telling NATO it’s useless, ripping up international climate treaties, and threatening to remove troops from the Middle East and beyond. US foreign policy would again flourish under the steady, practiced hands of the experts.
Then Biden blurted out in a television interview that President Putin was a killer with no soul. Then US Secretary of State Antony Blinken discovered the hard way that his Chinese counterparts were in no mood to be lectured on an “international rules-based order” that is routinely flouted by Washington.
It’s going to be a rough ten days for President Biden. Just as news breaks that under the Obama/Biden Administration the US was routinely and illegally spying on its European allies, he is preparing to meet those same allies, first at the G7 summit in England on June 11-13 and then at the June 14th NATO meeting in Brussels.
Make no mistake, Joe Biden is up to his eyeballs in this scandal. Ed Snowden Tweeted late last month when news broke that the US teamed up with the Danes to spy on the rest of Europe, that “Biden is well-prepared to answer for this when he soon visits Europe since, of course, he was deeply involved in this scandal the first time around.”
Though Germany’s Merkel and France’s Macron have been loyal US lapdogs, the revelation of how Washington treats its allies has put them in the rare position of having to criticize Washington. “Outrageous” and “unacceptable” are how they responded to the news.
Russia has been routinely accused (without evidence) of malign conduct and interference in internal US affairs, but it turns out that the country actually doing the spying and meddling was the US all along – and against its own allies!
Surely this irony is not lost on Putin.
Biden has bragged in the US media that he would be taking Putin to task for Russia’s treatment of political dissidents like Alexei Navalny. Biden wrote recently in the Washington Post, that when he meets Putin, “I will again underscore the commitment of the United States, Europe and like-minded democracies to stand up for human rights and dignity.”
Perhaps President Putin will remind him of how the Biden Administration continues the slow-motion murder of Julian Assange for the non-crime of being a journalist exposing government misdeeds.
Perhaps Putin will remind Biden of how US political dissidents are being treated, such as the hundreds arrested for what the Democrats and the mainstream media laughably call the “January 6th Insurrection.” Many of these non-violent and unarmed protesters have been held in solitary confinement with no chance of bail, even though they have no prior arrests or convictions. Most await trial on minor charges that may not even take place until next year.
The Washington foreign policy establishment is hopelessly corrupt. The weaponization of the US dollar to bring the rest of the world to heel is backfiring. Only a serious change in course – toward non-interventionism and non-aggression – can avert a disaster. Time is running out.
Copyright © 2021 by RonPaul Institute
White House admits CIA involvement in “War on Corruption” which jailed Lula and elected Bolsonaro
Brasil Wire – June 3, 2021
In a White House ‘Background Press Call by Senior Administration Officials on the Fight Against Corruption’, a Biden administration official admitted that the CIA and other parts of the U.S. intelligence apparatus were involved in assisting the “War on Corruption” which jailed former president Luiz Inacio Lula da Silva and elected Jair Bolsonaro.
Read the full transcript here.
The admission will come as an embarrassment to a media who has for the most part omitted, minimised or denied U.S. involvement in anti-corruption actions across Latin America, despite it being a matter of public record for years.
In July 2017, Acting Assistant Attorney General Kenneth A. Blanco gave a speech at NATO think tank the Atlantic Council in which he bragged of FBI personnel informally involved in Brazilian anti-corruption operation Lava Jato and its prosecution of former president Lula. FBI personnel involved later boasted that it had “toppled presidents“. Lava Jato prosecutor Deltan Dellagnol described Lula’s 2018 arrest which kept him out of the election he was on course to win, as “a gift from the CIA“. The judge who prosecuted Lula, Sergio Moro, became Bolsonaro’s Justice Minister, and both made an unprecedented visit to CIA headquarters in Langley within months of taking office. Lava Jato’s origins can be traced back to 2008/09, where Moro and a blueprint for an operation of its type appear in State Department cables.
The role of anti-corruption as U.S. foreign policy tool in Latin America has expanded gradually since the 1990s, and has continued through successive Democrat and Republican administrations. Lava Jato was central to the ouster of president Dilma Rousseff, and pivotal to the election of Jair Bolsonaro, which were both undeniably advantageous to the United States government and business/banking sector, which is represented in Latin America by lobby and think tank Council of the Americas.
The June 3 press call was to mark a new national security study memorandum or NSSM on “Establishing the fight against corruption as a core U.S. national security interest“, which is being renewed under the Biden administration, and held by unnamed “senior administration officials”.
The following exchange left little to the imagination.
Journalist: “As you know, anti-corruption activists periodically urge the U.S. government to use its various assets and capabilities, including the intelligence community, to expose specific cases of corruption overseas, to name and shame corrupt officials — and the arguments they make are familiar — but also include not only, you know, a deterrent to corruption, but also a possible contribution to the promotion of democracy. Does the memorandum — does the program include any component that connects with that?”
Senior Administration Official: “What I can say on that front is that the memorandum includes components of the intelligence community. So, the work on that front, in part, remains to be seen, but they are included — the Director of National Intelligence and Central Intelligence Agency.”
“And so we’re just going to be looking at all of the tools in our disposal to make sure that we identify corruption where it’s happening and take appropriate policy responses.”
“And I’ll take the opportunity to mention that we’re also going to be using this effort to think about what more we can do to bolster other actors that are out in the world exposing corruption and bringing it to light.”
“So, of course, the U.S. government has its own internal methods, but, largely, the way that corruption is exposed is through the work of investigative journalists and investigative NGOs.”
“The U.S. government — to my point earlier, in terms of the support we’re already providing — in some instances provides support to these actors. And we’ll be looking at what more we can do on that front as well.”
The journalist asked for clarification: “What does the word “support” mean in that context?”
Senior Administration Official: “Well, sometimes it boils down to foreign assistance. There are lines of assistance that have jumpstarted investigatory journalism organizations. What comes to my mind most immediately is OCCRP, as well as foreign assistance that goes to NGOs, ultimately, that do investigative work on anti-corruption, as well.”
Evidence of the very nature that the official describes above has been dismissed by supporters of partisan anti-corruption campaigns for years.
The official was asked by a journalist specifically about Vice President Kamala Harris’s upcoming trip to Latin America, and: “if there were any corruption measures associated with that, or any, sort of, additional push related to that?”
The unnamed official responded: “I’m not going to characterize the views of the prior administration, but I would say, to your point: The essence of the memorandum we’re going to release today is that the U.S. government is placing the anti-corruption plight at the center of its foreign policy, so we very much want to prioritize this work across the board.”
The latest admission of CIA involvement in the U.S. led “fight against corruption”, of which Operation Lava Jato (Carwash) was the high-profile centrepiece, has grave implications for Brazilian democracy, and that of wider Latin America.
Brasil Wire has been covering this subject in depth since 2015: All articles on Lawfare in Brazil and U.S. involvement in it, 2015-2021.






